These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1472 related items for PubMed ID: 30696744

  • 1. Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance.
    Kim SH, Iyer KR, Pardeshi L, Muñoz JF, Robbins N, Cuomo CA, Wong KH, Cowen LE.
    mBio; 2019 Jan 29; 10(1):. PubMed ID: 30696744
    [Abstract] [Full Text] [Related]

  • 2. Upc2-mediated mechanisms of azole resistance in Candida auris.
    Li J, Aubry L, Brandalise D, Coste AT, Sanglard D, Lamoth F.
    Microbiol Spectr; 2024 Feb 06; 12(2):e0352623. PubMed ID: 38206035
    [Abstract] [Full Text] [Related]

  • 3. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90.
    LaFayette SL, Collins C, Zaas AK, Schell WA, Betancourt-Quiroz M, Gunatilaka AA, Perfect JR, Cowen LE.
    PLoS Pathog; 2010 Aug 26; 6(8):e1001069. PubMed ID: 20865172
    [Abstract] [Full Text] [Related]

  • 4. The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance.
    Shapiro RS, Zaas AK, Betancourt-Quiroz M, Perfect JR, Cowen LE.
    PLoS One; 2012 Aug 26; 7(9):e44734. PubMed ID: 22970302
    [Abstract] [Full Text] [Related]

  • 5. The Proteasome Governs Fungal Morphogenesis via Functional Connections with Hsp90 and cAMP-Protein Kinase A Signaling.
    Hossain S, Veri AO, Cowen LE.
    mBio; 2020 Apr 21; 11(2):. PubMed ID: 32317319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic Candida Species.
    Revie NM, Robbins N, Whitesell L, Frost JR, Appavoo SD, Yudin AK, Cowen LE.
    mSphere; 2020 Apr 08; 5(2):. PubMed ID: 32269162
    [Abstract] [Full Text] [Related]

  • 13. Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
    Li J, Coste AT, Bachmann D, Sanglard D, Lamoth F.
    Antimicrob Agents Chemother; 2022 Apr 19; 66(4):e0006722. PubMed ID: 35343781
    [Abstract] [Full Text] [Related]

  • 14. A Zinc Cluster Transcription Factor Contributes to the Intrinsic Fluconazole Resistance of Candida auris.
    Mayr EM, Ramírez-Zavala B, Krüger I, Morschhäuser J.
    mSphere; 2020 Apr 22; 5(2):. PubMed ID: 32321822
    [Abstract] [Full Text] [Related]

  • 15. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
    Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J.
    Antimicrob Agents Chemother; 1999 Nov 22; 43(11):2753-65. PubMed ID: 10543759
    [Abstract] [Full Text] [Related]

  • 16. Hsp90 governs dispersion and drug resistance of fungal biofilms.
    Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE.
    PLoS Pathog; 2011 Sep 22; 7(9):e1002257. PubMed ID: 21931556
    [Abstract] [Full Text] [Related]

  • 17. Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates.
    Alabi PE, Gautier C, Murphy TP, Gu X, Lepas M, Aimanianda V, Sello JK, Ene IV.
    mBio; 2023 Aug 31; 14(4):e0047923. PubMed ID: 37326546
    [Abstract] [Full Text] [Related]

  • 18. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
    Gaur NA, Manoharlal R, Saini P, Prasad T, Mukhopadhyay G, Hoefer M, Morschhäuser J, Prasad R.
    Biochem Biophys Res Commun; 2005 Jun 24; 332(1):206-14. PubMed ID: 15896319
    [Abstract] [Full Text] [Related]

  • 19. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH.
    Dan Med J; 2016 Oct 24; 63(10):. PubMed ID: 27697142
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.